课题基金 / 基金详情

Immunological therapies for cancer and autoimmunity

Immunological therapies for cancer and autoimmunity
癌症和自身免疫的免疫疗法
批准号:
nhmrc : 351439
负责人:
Prof Geoff Hill
金额:
$328.62万
依托单位国家:
澳大利亚
项目类别:
Programs
财政年份:
2005
资助国家:
澳大利亚
项目状态:
已结题
起止时间:
2005-01-01 至 2009-12-31

项目摘要

项目成果

Prof Geoff Hill的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
The programme team comprises a group of leading scientists with a history of successful investigation into the mechanisms and treatment of diseases in which the immune system plays a role in their development. These include cancers of the cervix and blood system, and autoimmune diseases such as rheumatoid arthritis and type 1 diabetes. Working together, the team have made discoveries that have led to testing and clinical development of new treatments for these diseases. In this programme, the team aims to discover mechanisms regulating the immune response, and to exploit this knowledge to define new ways of switching on or off, specific immune responses. We will particularly seek to develop novel vaccines for chronic infections and autoimmune diseases, and to improve the safety of bone marrow transplantation.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Imroving transplantation outcomes
  • 批准号:
    nhmrc : GNT1107797
  • 项目类别:
    Research Fellowships
  • 资助金额:
    $92.7万
  • 财政年份:
    2016
  • 负责人:
    Prof Geoff Hill
  • 依托单位:
Imroving transplantation outcomes
  • 批准号:
    nhmrc : 1107797
  • 项目类别:
    Research Fellowships
  • 资助金额:
    $63.74万
  • 财政年份:
    2016
  • 负责人:
    Prof Geoff Hill
  • 依托单位:
Immunoregulation for treatment of disease
  • 批准号:
    nhmrc : 1071822
  • 项目类别:
    Program Grants
  • 资助金额:
    $821.22万
  • 财政年份:
    2015
  • 负责人:
    Prof Geoff Hill
  • 依托单位:
Immunoregulation for treatment of disease
  • 批准号:
    nhmrc : GNT1071822
  • 项目类别:
    Programs
  • 资助金额:
    $1179.75万
  • 财政年份:
    2015
  • 负责人:
    Prof Geoff Hill
  • 依托单位:
国内基金
海外基金
Autoimmune diseases therapies: variations on the microbiome in rheumatoid arthritis
Molecular Interaction Reconstruction of Rheumatoid Arthritis Therapies Using Clinical Data